TrialEuropean journal of haematology2025

Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies.

Alexander Röth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.